Cargando…

Vesicular MicroRNA as Potential Biomarkers of Viral Rebound

Changes in the cellular microRNA (miRNA) expression profile in response to HIV infection, replication or latency have been reported. Nevertheless, little is known concerning the abundance of miRNA in extracellular vesicles (EVs). In the search for a reliable predictor of viral rebound, we quantified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazié, Wilfried Wenceslas, Boucher, Julien, Traoré, Isidore Tiandiogo, Kania, Dramane, Somé, Diane Yirgnur, Alary, Michel, Gilbert, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909274/ https://www.ncbi.nlm.nih.gov/pubmed/35269481 http://dx.doi.org/10.3390/cells11050859

Ejemplares similares

Plasma vesicular miR-155 as a biomarker of immune activation in antiretroviral treated people living with HIV
por: Bazié, Wilfried Wenceslas, et al.
Publicado: (2022)

HIV Replication Increases the Mitochondrial DNA Content of Plasma Extracellular Vesicles
por: Bazié, Wilfried Wenceslas, et al.
Publicado: (2023)

Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso
por: Bazié, Wilfried Wenceslas, et al.
Publicado: (2022)

Diurnal Variation of Plasma Extracellular Vesicle Is Disrupted in People Living with HIV
por: Bazié, Wilfried Wenceslas, et al.
Publicado: (2021)

Plasma Extracellular Vesicle Subtypes May be Useful as Potential Biomarkers of Immune Activation in People With HIV
por: Bazié, Wilfried Wenceslas, et al.
Publicado: (2021)

Immune Cells Release MicroRNA-155 Enriched Extracellular Vesicles That Promote HIV-1 Infection
por: Boucher, Julien, et al.
Publicado: (2023)

Velocity Gradient Separation Reveals a New Extracellular Vesicle Population Enriched in miR-155 and Mitochondrial DNA
por: Vaillancourt, Myriam, et al.
Publicado: (2021)

Spatiotemporal analysis of dengue fever in Burkina Faso from 2016 to 2019
por: Ouattara, Cheick Ahmed, et al.
Publicado: (2022)

Climate factors and dengue fever in Burkina Faso from 2017 to 2019
por: Ouattara, Cheick Ahmed, et al.
Publicado: (2022)

Cervical pre-cancer screening by visual inspection of the cervix after application of acetic acid in rural Burkina Faso: evaluation of women’s knowledge, screening practice habits, acceptability and prevalence of risk factors and lesions in Boussé health district
por: Tassembedo, Souleymane, et al.
Publicado: (2023)

To rebound or not to rebound
por: Stahl, Bethany A, et al.
Publicado: (2017)

COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso
por: Traoré, Isidore Tiandiogo, et al.
Publicado: (2021)

Delays in TB Diagnosis and Treatment Initiation in Burkina Faso during the COVID-19 Pandemic
por: Diallo, Adama, et al.
Publicado: (2022)

Spatio-Temporal Determinants of Dengue Epidemics in the Central Region of Burkina Faso
por: Ouattara, Cheick Ahmed, et al.
Publicado: (2023)

Viral and Symptom Rebound in Untreated COVID-19 Infection
por: Deo, Rinki, et al.
Publicado: (2022)

Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19
por: Anderson, Annaliesa S., et al.
Publicado: (2022)

Viral suppression and viral rebound among young adults living with HIV in Canada
por: Palmer, Alexis, et al.
Publicado: (2018)

The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy
por: Huntington, Susie, et al.
Publicado: (2015)

Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features
por: Bartsch, Yannic C., et al.
Publicado: (2021)

Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13)
por: Kaboré, Nongodo Firmin, et al.
Publicado: (2023)

Isolation and characterization of vesicular and non-vesicular microRNAs circulating in sera of partially hepatectomized rats
por: Castoldi, Mirco, et al.
Publicado: (2016)

Hepatitis Rebound after Infection with Yellow Fever Virus
por: Denis, Blandine, et al.
Publicado: (2019)

The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population‐based, age‐stratified sero‐epidemiological investigation
por: Ouedraogo, Samiratou, et al.
Publicado: (2023)

Potential biomarkers: Predicting post-treatment viral rebound in rhesus macaques
por: Yang, Chenbo, et al.
Publicado: (2023)

Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover
por: Roberts, Thomas C., et al.
Publicado: (2013)

Adherence to HIV Antiretroviral Therapy Among Pregnant and Breastfeeding Women, Non-Pregnant Women, and Men in Burkina Faso: Nationwide Analysis 2019–2020
por: Zoungrana-Yameogo, Wedminere Noëlie, et al.
Publicado: (2022)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
por: Hurst, Jacob, et al.
Publicado: (2015)

Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys
por: Borducchi, Erica N., et al.
Publicado: (2018)

994. Risk for Viral Rebound in the Era of U=U; A CNICS Analysis
por: Hansen, Blake, et al.
Publicado: (2020)

Ins and Outs of Reovirus: Vesicular Trafficking in Viral Entry and Egress
por: Roth, Alexa N., et al.
Publicado: (2021)

Uptake of prevention of mother-to-child transmission cascade services in Burkina Faso between 2013 and 2020: are we on the right track?
por: Fassinou, Lucresse Corine, et al.
Publicado: (2023)

Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
por: Conway, Jessica M., et al.
Publicado: (2019)

Multidrug-resistant HIV viral rebound during early syphilis: a case report
por: Giacomelli, Andrea, et al.
Publicado: (2020)

A multidimensional HIV-1 persistence model for clonal expansion and viral rebound in vitro
por: Eshetu, Amare, et al.
Publicado: (2021)

Remdesivir/tocilizumab: Rebound of HCV viral load and loss of anti-HBs: case report
Publicado: (2021)

Unified model of short- and long-term HIV viral rebound for clinical trial planning
por: Conway, Jessica M., et al.
Publicado: (2021)

Factors associated with viral rebound among COVID-19 patients receiving oral antivirals
por: Chen, Pao-Yu, et al.
Publicado: (2023)

Pseudoxanthome élastique généralisé et évolutif chez une mélanoderme
por: Andonaba, Jean Baptiste, et al.
Publicado: (2013)

Viral meningitis epidemics and a single, recent, recombinant and anthroponotic origin of swine vesicular disease virus
por: Bruhn, Christian A. W., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lf6uqa8t4tqcrdq810j73g8efk